4/AFiled Aug 6, 8:00 PM ET

OKYO Pharma (OKYO) 10% Owner Cerrone Buys 22,500 Shares

$OKYO · OKYO Pharma Ltd

Research Summary

AI-generated summary of this SEC filing

Updated

OKYO Pharma (OKYO) 10% Owner Cerrone Buys 22,500 Shares

What Happened

  • Gabriele M. Cerrone, a reported 10% owner of OKYO Pharma (ticker: OKYO), acquired 22,500 shares in an open-market/private purchase on July 21, 2026. The purchase price was $1.45 per share for a total of $32,625.
  • This filing is a Form 4/A that amends the Form 4 originally filed on July 23, 2026 solely to correct the transaction code associated with the purchase; no economic terms of the transaction were changed.

Key Details

  • Transaction date and price: 2026-07-21 — 22,500 shares at $1.45 each (total $32,625).
  • Transaction type/code: P = Purchase (open market or private purchase).
  • Filing timeline: Original Form 4 filed July 23, 2026 (two days after the trade); this amended Form 4/A filed August 7, 2026 to correct the code.
  • Shares owned after transaction: Not specified in this amendment; refer to the original Form 4 for holdings reported at that time.
  • No 10b5-1 plan, tax withholding, or other special footnotes are reported in this amendment.

Context

  • As a 10% owner, Cerrone is a significant shareholder; purchases by large holders can be of interest but do not alone indicate company outlook or operational changes.
  • This is a straightforward buy (not an option exercise, award, or gift). The amendment only fixes a reporting code and does not alter the reported economic details of the purchase.